Eplerenone pharmaceutical composition
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING D VENTUREPHARM TECH DEV
- Publication Date
- 2008-04-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention relates to an antihypertensive pharmaceutical composition, in particular to a pharmaceutical composition containing eplerenone. Background technique
[0002] Eplerenone is a selective aldosterone inhibitor (SAB) that specifically inhibits the function of the hormone aldosterone. Aldosterone is an important component of the renin-angiotensin-aldosterone system (RAAS), which plays an important role in regulating the function of the human cardiovascular system. Its chemical structure is as follows:
[0003]
[0004] Eplerenone can effectively control high blood pressure, reduce damage to target organs such as the heart, brain and kidney, and improve microalbuminuria in patients with type 2 diabetes. The incidence of side effects is similar to that of placebo, and it is well tolerated. It is of great significance for the control of hypertension in hypertensive patients, the prevention of cardiovascular diseases related to target organ dam...